• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

TAK 438 xC4H4O4

Vonoprazan Fumarate is an orally active potassium-competitive acid blocker which inhibits H+, K+-ATPase activity with an IC50 of 19 nM.

CAS号

2098974-13-9

分子式

C21H20FN3O6S

主要靶点

Proton Pump

仅限科研使用

Cat No : CM06215

Print datasheet

Synonyms

验证数据展示

  • CAS No.: 2098974-13-9

    TAK 438 xC4H4O4
    CAS#: 2098974-13-9

  • TAK 438 xC4H4O4<br/>CAS#: 2098974-13-9

    TAK 438 xC4H4O4
    CAS#: 2098974-13-9

产品信息

Vonoprazan Fumarate is an orally active potassium-competitive acid blocker which inhibits H+, K+-ATPase activity with an IC50 of 19 nM.

CAS号 2098974-13-9
分子式 C21H20FN3O6S
主要靶点 Proton Pump
主要通路 Membrane Transporter/Ion Channel
分子量 461.4634
MDL NO
Pubchem ID 45375887.0
纯度 97%， 此纯度可做参考，具体纯度与批次有关系，可咨询客服
储存条件
粉末 -20°C 3年
液体 -80°C 1年
运输条件 Shipped in cold pack
别名

靶点

TargetActivity

溶解度

DMSO50 mg/mL

参考文献

1Arikawa Y, et al. Discovery of a novel pyrrole derivative 1-
2Hori Y, et al. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals. J Pharmacol Exp Ther, 2011, 337(3), 797-804.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2